CHICAGO, May 4, 2021 /PRNewswire/ -- According to the new
market research report "Custom Antibody Market by Service
(Antibody Development, Production, Labelling), Type (Monoclonal,
Polyclonal, Recombinant), Source (Rabbit, Mice), Research Area
(Oncology, Immunology), End User (Pharmaceutical Companies, CROs) -
Global Forecast to 2026", published by MarketsandMarkets™, the
global market is projected to reach USD 652
million by 2026 from USD 393
million in 2021, at a CAGR of 10.6% during the forecast
period.
Browse in-depth TOC on "Custom Antibody Market"
166 – Tables
29 – Figures
189 – Pages
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164328301
As such, an increase in research activity-especially in the life
sciences industry-along with growing industry-academia
collaborations are the primary growth drivers for this market. In
addition, the objective behind custom antibody production is to
acquire an antibody that performs well in a particular qualitative
or quantitative immunodetection method. The quality of catalog
antibodies (to ensure the reproducibility of results) is also an
area of concern in this market, which is primarily why end users
prefer custom-made antibodies.
Antibody Development accounted for the largest share of
custom antibody market
Based on service, the market is segmented into antibody
development, antibody production & purification, and antibody
fragmentation & labeling. Antibody development services
accounted for the largest market share of 56.6% in 2020. The large
share of this segment can be attributed to the increasing focus of
researchers on high-quality antibodies for reproducibility, which
can be hampered by using commercially available antibodies.
Monoclonal antibody accounted for the largest share of custom
antibody market
Based on type, the market is segmented into monoclonal
antibodies, polyclonal antibodies, recombinant antibodies, and
other custom antibodies. The recombinant antibodies segment is
projected to witness the highest growth rate during the forecast
period. The increasing development of recombinant antibodies due to
advantages such as batch-to-batch reproducibility and rapid
production is propelling the growth of this market segment.
Pharmaceutical & biotechnology companies is the
fastest-growing end user segment of the custom antibody
market
Based on end user, the market is segmented into pharmaceutical
& biotechnology companies, academic & research institutes,
and contract research organizations. The pharmaceutical &
biotechnology companies segment held the largest share of the
custom antibody market in 2020. The large share of this segment is
attributed to the increasing demand for high-specificity antibodies
for drug discovery and development, increasing research in the
areas of genomics and proteomics, and the need for antibodies in
the identification of new targets and assays. Additionally, the
impact of COVID-19 has encouraged various pharmaceutical companies
to enter into collaborations with custom antibody service providers
to develop COVID-19 antibodies.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=164328301
North America accounted for
the largest share of the custom antibody market
North America accounted for the
largest share of the custom antibody market, followed by
Europe in 2019. The dominance of
the North American region can be attributed to the increasing
investments in the development of structure-based drug designs,
growing research in the fields of genomics and proteomics, rising
demand for high-quality research tools for data reproducibility,
increasing focus on developing antibody-based therapeutics, and the
presence of a large number of global players in this region. On the
other hand, the Asia Pacific
market is estimated to witness the highest growth during the
forecast period, primarily due to the increasing investments by
governments and industries, growing biotechnology research, and
rising awareness on personalized therapeutics.
Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc.
(US), Merck Group (Germany), Cell
Signaling Technology, Inc. (US), GenScript (China), BioLegend (US), Rockland
Immunochemicals (US)
Speak to Analyst:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=164328301
Browse Adjacent Markets: Biotechnology Market
Research Reports & Consulting
Browse Related Reports:
Neuroscience Antibodies & Assays Market by Product
(Reagent (Media, Sera, Stain, Enzymes, Probe), Instruments),
Technology (Immunoassay (Elisa), Molecular Diagnostics),
Application (IVD) & End User (Research Institute, Hospital) -
Global Forecast to 2023
https://www.marketsandmarkets.com/Market-Reports/neuroscience-antibodies-assays-market-129888612.html
Research Antibodies & Reagents Market by Product
(Antibodies (Type, Form, Source, Research Area), Reagents),
Technology (Western blotting, Flow Cytometry), Application
(Proteomics, Drug Development), End User - COVID-19 Impact - Global
Forecast to 2025
https://www.marketsandmarkets.com/Market-Reports/research-antibodies-reagents-market-94212793.html
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000
high growth niche opportunities/threats which will impact 70% to
80% of worldwide companies' revenues. Currently servicing 7500
customers worldwide including 80% of global Fortune 1000 companies
as clients. Almost 75,000 top officers across eight industries
worldwide approach MarketsandMarkets™ for their painpoints around
revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are
tracking global high growth markets following the "Growth
Engagement Model – GEM". The GEM aims at proactive collaboration
with the clients to identify new opportunities, identify most
important customers, write "Attack, avoid and defend" strategies,
identify sources of incremental revenues for both the company and
its competitors. MarketsandMarkets™ now coming up with 1,500
MicroQuadrants (Positioning top players across leaders, emerging
companies, innovators, strategic players) annually in high growth
emerging segments. MarketsandMarkets™ is determined to benefit more
than 10,000 companies this year for their revenue planning and help
them take their innovations/disruptions early to the market by
providing them research ahead of the curve.
MarketsandMarkets' flagship competitive intelligence and market
research platform, "Knowledge Store" connects over 200,000 markets
and entire value chains for deeper understanding of the unmet
insights along with market sizing and forecasts of niche
markets.
Contact:
Mr. Aashish
Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight:
https://www.marketsandmarkets.com/ResearchInsight/custom-antibody-market.asp
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source:
https://www.marketsandmarkets.com/PressReleases/custom-antibody.asp
Logo:
https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg